Sale by Xiaolin Wang of 714 shares of Revolution Medicines
| RVMDW Stock | 0.34 0.01 2.86% |
Slightly above 54% of Revolution Medicines,'s sophisticated investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Revolution Medicines, Warrant suggests that some traders are interested. Revolution Medicines,'s investing sentiment can be driven by a variety of factors including economic data, Revolution Medicines,'s earnings reports, geopolitical events, and overall market trends.
Revolution |
Filed transaction by Revolution Medicines Inc officer. General open market or private sale of non-derivative or derivative security
Read at macroaxis.com
Cash Flow Correlation
Revolution Medicines,'s cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Revolution Medicines,'s relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Revolution Medicines, Fundamental Analysis
We analyze Revolution Medicines,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revolution Medicines, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revolution Medicines, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Revolution Medicines, is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Revolution Medicines, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Revolution Medicines, stock to make a market-neutral strategy. Peer analysis of Revolution Medicines, could also be used in its relative valuation, which is a method of valuing Revolution Medicines, by comparing valuation metrics with similar companies.
Peers
Revolution Medicines, Related Equities
| RBC | RBC Bearings | 1.73 | ||||
| AEG | Aegon NV | 1.10 | ||||
| QBEIF | QBE Insurance | 0.00 | ||||
| TTC | Toro | 0.17 | ||||
| ORI | Old Republic | 0.36 | ||||
| PLMR | Palomar Holdings | 0.83 | ||||
| GOCO | GoHealth | 3.69 |
Additional Tools for Revolution Stock Analysis
When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.